Introduction Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) is a highly
personalized type of cancer immunotherapy. TIL-based ACT exploits naturally occurring …

Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy by
harvesting infiltrated lymphocytes from tumors, culturing and amplifying them in vitro and …

The rationale behind cancer immunotherapy is based on the unequivocal demonstration
that the immune system plays an important role in limiting cancer initiation and progression …

Adoptive cell therapy (ACT) with tumor-infiltrating T cells (TILs) has emerged as a promising
therapy for the treatment of unresectable or metastatic solid tumors. One challenge to finding …

Autologous adoptive T-cell therapies have made tremendous strides over the last few years
with excitement currently being generated by technologies that can reprogram T-cell …

Cancer immunotherapy has become an important area for the future development of cancer
therapy; this includes T-cell-based therapies that involve adoptive transfer of autologous T …

Adoptive T-cell therapy (ACT) using expanded autologous tumor-infiltrating lymphocytes
(TIL) and tumor antigen-specific T cell expanded from peripheral blood are complex but …

Adoptive cell therapy (ACT) based on autologous T cell derived either from tumor as tumor-
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …

Background Various immunotherapeutic strategies for cancer are aimed at augmenting the
T cell response against tumor cells. Adoptive cell therapy (ACT), where T cells are …

Simple Summary Over the past decade, cell-based immunotherapy has become a powerful
strategy in solid cancer therapy. Tumor-infiltrating lymphocytes (TILs) are a group of …